期刊文献+

马兜铃水提液对斑马鱼胚胎的致畸作用和心脏毒性的研究 被引量:5

Study on Teratogenesis and Cardiac Toxicity of Aqueous Extraction of Aristolochia contorta to Zebrafish Embryos
下载PDF
导出
摘要 目的:探索马兜铃水提液对斑马鱼胚胎的致畸作用和心脏毒性。方法:分别用不同浓度的马兜铃水提液和马兜铃酸A(AA)处理斑马鱼胚胎,观察致畸作用和对心脏发育影响。结果:给药组的斑马鱼胚胎出现畸形和死亡;当水提液中AA含量为0.5μg/mL时,胚胎心率明显减慢;AA含量为5μg/mL时,胚胎在24~48 hpf之间全部死亡;水提液的LC50为1.43μg/mL。结论:与AA相比,马兜铃水提液对斑马鱼胚胎有着更强的致畸和心脏毒性,且毒性作用具有时间和浓度依赖性。 Object: To explore the developmental toxicity of aqueous extraction of Aristolochia contorta to zebrafish embryos. Methods: Aristolochic acid A (AA) was first tested on zebrafish embryo model to ob- serve the teratogenesis and cardiac effect. Then aqueous extraction of Aristolochia contorta was investiga- ted on wild type zebrafish embryos, and the zebrafish embryos were observed under microscope to see the teratogenesis and cardiac effect. Results: After soaking zebrafish embryos in aqueous extraction for 42 h, the embryos displayed malformed phenotypes. Besides the concentration of AA reaching 0.5 p.g/mL, the heart beats reduced obviously compared to the control group. When the concentration of AA was more than 5 p^g/mL, none of the embryos survived after 48 hpf. The heart rates of all the tested groups of Aris- tolochia contorta were lower than that of the control group. The LCs0 of Aristolochia contorta was 1. 43 μg/ mL. Conclusions: Aristolochia contorta displayed stronger toxicity to embryos including teratogenesis, cardiac toxicity and developmental inhibition than AA.
出处 《中国野生植物资源》 2013年第6期10-13,共4页 Chinese Wild Plant Resources
关键词 马兜铃 斑马鱼胚胎 马兜铃酸A 致畸 心脏毒性 Aristolochia contorta Zebrafish embryo Aristolochic acid teratogenesis cardiac toxicity
  • 相关文献

参考文献9

  • 1许玉琼,尚明英,葛跃伟,王璇,蔡少青.马兜铃化学成分研究[J].中国中药杂志,2010,35(21):2862-2865. 被引量:12
  • 2Arlt V M, Stiborova M, Schmeiser H H. Aristolochic acid as aprobable human cancer hazard in herbal remedies : a review [ J].Mutagenesis. 2002,17(4) :265 -277.
  • 3郭晓昕,程鲁榕.马兜铃酸毒理学性研究与启示[J].中国新药杂志,2005,14(3):363-366. 被引量:13
  • 4Cui M,Liu Z H, Qiu Q,et al. Tumour induction in rats followingexposure to short - term high dose aristolochic acid I [ J]. Mutagen-esis. 2005,20(1) :45 -49.
  • 5Monte W. The zebrafish book a guide for the laboratory use of ze-brafish (Dario rerio) [ M]. Edition 4. Printed by the Universityof Oregon Press,2000:253.
  • 6Charles B K,William W B,Seth R K, et al. Stages of EmbryonicDevelopment of the Zebrafish [ J]. Developmental Dynamics,1995,203(3) :253 -310.
  • 7OECD. OECD Guideline for the Testing of Chemicals. Draft Pro-posal for a New Guideline Fish Embryo Toxicity ( FET) Test.OECD, Paris. Draft Guideline,2006.
  • 8刘美凤,刘璟,吕浩然,周惠.马兜铃提取条件的优化以及炮制减毒的研究[J].广州化工,2011,39(9):83-85. 被引量:2
  • 9李彪,李晓玫,张翠英,王璇,蔡少青.马兜铃内酰胺I对肾小管上皮细胞的损伤作用[J].中国中药杂志,2004,29(1):78-83. 被引量:39

二级参考文献52

  • 1陈业高,于丽丽.北马兜铃化学成分的研究[J].云南师范大学学报(自然科学版),2005,25(3):41-44. 被引量:7
  • 2曾美怡,李敏民,赵秀文.关于马兜铃酸类成分的毒性反应[J].中药新药与临床药理,1995,6(2):48-50. 被引量:66
  • 3彭国平,楼凤昌,赵守训.管花马兜铃化学成分的研究[J].药学学报,1995,30(7):521-525. 被引量:8
  • 4庞晓军.马兜铃酸的毒理学现状[J].中国医院用药评价与分析,2006,6(1):47-49. 被引量:3
  • 5徐丽珍 孙南军.穆坪马兜铃化学成分的研究[J].药学学报,1984,19(1):48-55.
  • 6徐国钧,徐珞珊.常用中药材品种整理和质量研究.第1册[M].福州:福建科学技术出版社,1994:673.
  • 7Zhang C Y, Wang X, Su T, et al. New aristolochic acid, aristololactam and renal cytotoxic constituents from the stem and leaves of Aristolochia contorta[ J]. Pharmazie,2005,60(10) :785.
  • 8Yu L L, Huang R, Lv Y P, et al. A new biflavonoid from Aristolochia contorta[ J]. Pharmazie,2005,60(10) :789.
  • 9Horacio A, Priestap. Minor aristolochic acids from Aristolochia argentina and mass spectral analysis of aristolochic acids[ J]. Phytochemistry, 1987,26 ( 2 ) : 519.
  • 10Horatio A, Priestap. Seven aristololactams from Aristolochia argentina[ J]. Phytochemistry, 1985,24(4) :849.

共引文献61

同被引文献83

  • 1林娜,胡建平.中药胚胎毒性的研究现状和展望[J].中国中药杂志,2005,30(17):1317-1320. 被引量:15
  • 2董永新,王跃祥,钱林溪,蒋璆,刘学飞,宋后燕.桔梗皂苷对斑马鱼心功能及胚胎发育的影响[J].中国临床药学杂志,2006,15(5):299-303. 被引量:10
  • 3blACRAE CA. PETERSON RT. Zebrafish as tools for drug dis-covery[J]. NatRevDrugDiscov, 2015, 14(10): 721 -731.
  • 4CLARK MD, HENNIG S, HERWIG R, et al. An oligonucleoti- de fingerprint normalized and expressed sequence tag character- ized zebrafish cDNA library[ J]. Genome Res, 2001, 11 (9) : 1594 - 1602.
  • 5LI CQ, LUO LQ, AWERMAN J, PATRICIA MG. Whole Ze- brafish Cytochrome P450 Assay for Assessing Drug Metabolism and Safety[ M ]//Patricia McGrath. Zebrafish: Methods for As- sessing Drug Safety and Toxicity. USA. John Wiley & Sons, Inc, 2011 : 103 - 115.
  • 6CRAWFORD AD, ESGUEIRRA CV, WITTE PAMD. Fishing for drugs from nature: Zebrafish as a technology platform for natural product discovery [ J ]. Planta Med, 2008, 74 (6) : 624 - 632.
  • 7JYOTSHNA K, ELVIC C, ALl SF, et al. Zebrafish model in drug safety assessment[ J]. Curr Pharm Design, 2014, 20(34) : 5416 - 5429.
  • 8HE JH, GUO SY, ZHU F, et al. A zebrafish phenotypic assay for assessing drug-induced hepatotoxicity[ J]. J Pharmacological Toxicol, 2013, 67(1): 25-32.
  • 9ZHU JJ, XU YQ, HE JH, et al. Human eardiotoxie drugs deliv- ered by soaking and microinjeetion induce cardiovascular toxicity in zebrafish[ J]. J Appl Toxieol, 2014, 34 (2) : 139 - 148.
  • 10HILL A, MESENS N, STEEMANS M, et al. Comparisons be- tween in vitro whole cell imaging and in vivo zebrafish-based ap- proaches for identifying potential human hepatotoxieants earlier in pharmaceutical development [ J l. Drug Metab Rev, 2012, 44 (1): 127-140.

引证文献5

二级引证文献69

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部